Therefore, in addition to supporting leukocyte infiltration into the liver and the development of NASH, CD44 may be a keystone to the systemic pathogenesis of obesity-associated diseases and the metabolic syndrome. This evidence concerns the gene CD44 and metabolic dysfunction-associated steatohepatitis.